Sichuan Kelun-Biotech Biopharmaceutical Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Access all reports
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a China-based company engaged in the research, development, and manufacturing of biopharmaceutical products. The company focuses on innovative therapeutics across various medical fields, including oncology, infectious diseases, and autoimmune disorders. It develops biologic drugs and biosimilars, utilizing advanced biotechnological platforms to address unmet medical needs. Sichuan Kelun-Biotech serves both domestic and international pharmaceutical markets. The company is headquartered in Chengdu, China, and its shares are listed on the Hong Kong Stock Exchange.
Key slides for Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
H1 2024
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
H1 2024
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
Latest articles
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Mips: The Gore-Tex of Brain Protection
How Mips turned a critical safety flaw into a global success, redefining helmet protection with its technology and ingredient brand business model.
24 Jan 2025
Ticker symbol
6990
Country
🇭🇰 Hong Kong